幽门螺杆菌工程疫苗研究进展

　　［5］Rupnow MF,Owens DK,Shachter R,Parsonnet J.Helicobacter pylori vaccine development and use:a cost-effectiveness analysis using the Instiute of Medicine methodology,Helicobacter,1999;4:272-280

　　［6］Dieterick C.Bouzourene H,Blum AL,Corthesy-Theulaz IE.Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice.Infect Immun,1999;67:6206-6209

　　［7］Ernst JD.Toward the development of antibacterial vaccines:report of a symposium and workshop.Organizing Committee.Clin Infect Dis,1999;29:1295-1302

　　［8］Blanchard TG,Czinn SJ,Nedrud JG,Killeen KP,Hohmann EL.Host response and vaccine development to Helicobacter pylori infection.Curr Top Microbiol immunol,1999;241:181-213

　　［9］Ghiara P,Rossi M,Marchetti M,Guidi L,Frasca D,Costanzo M.Therapeutic intragastric vaccination against Helicobacter Pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.Infect immune,1997;65:4996-5002

　　［10］Marchetti M,Rossi M,Giannelli V,Tricerri A,Guidi L.Protection against helicobacter pylori infection in mice by intragastric vaccination with helicobacter pylori antiens is achieved using a non-toxic mutant of E-coli heat-labile enterotoxin(LT)asadjuvant.Vaccine,1998;16:33-37

　　［11］韩锋产，阎小君，苏成芝.幽门螺旋杆菌细胞毒素相关蛋白A及细胞空泡毒素A的研究，华人消化杂志，1998；6：160-161

　　［12］Michetti P,Kreiss C,Kotloff K, Cahill R, Simmons C, Dougan G. Oral immunization of H,pylori infected adults with

　　［13］Kin SY,Doh HJ,Ahn JS,Tricerri D,Fuidi L,Induction of mucosal and systemic immune response by oral immunization with H,pylori lysates encapsulated in poly (D,L-lactide-co-glycolide)microparticles,Vaccine,1999;17:607-616

上一页  [1] [2] [3] [4] [5] [6] 下一页